Pneumocystis jirovecii pneumonia in non-Hodgkin’s lymphoma after rituximab-based chemotherapy: a case series

BACKGROUND: The incidence of Pneumocystis jirovecii pneumonia (PCP) has been increasing in patients with hematologic malignancies due to the use of glucocorticoid therapy and immunosuppressive medication. The reports of PCP in non-Hodgkin’s lymphoma (NHL) after rituximab-based chemotherapy are still...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qianying, Han, Liang, Lin, Yuanyuan, Sun, Xiaohong, Ye, Haige, Qian, Honglan, Sun, Lan, Jiang, Songfu, Liang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372200/
https://www.ncbi.nlm.nih.gov/pubmed/35966314
http://dx.doi.org/10.21037/tcr-22-1216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372200/
https://www.ncbi.nlm.nih.gov/pubmed/35966314
http://dx.doi.org/10.21037/tcr-22-1216

Ejemplares similares